Skip to main content
Cancer Cell International logoLink to Cancer Cell International
. 2016 May 31;16:40. doi: 10.1186/s12935-016-0316-3

Retraction Note: Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans

Guijuan Liu 1, Qiang Wu 2, Guilan Liu 3, Xueying Song 4, Jihong Zhang 2,
PMCID: PMC4888407  PMID: 27252596

Retraction to: Cancer Cell International (2015) 15:18 DOI 10.1186/s12935-014-0154-0

The editors are retracting this article [1] as it has been previously published in the International Journal of Clinical and Experimental Pathology [2] and it is therefore a redundant publication. The authors could not be reached by the journal for comment on the retraction.

Footnotes

The online version of the original article can be found under doi:10.1186/s12935-014-0154-0.

References

  • 1.Liu G, Wu Q, Liu G, Song X, Zhang J. Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans. Cancer Cell Int. 2015;15:18. doi: 10.1186/s12935-014-0154-0. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 2.Liu G, Wu Q, Liu G, Song X, Zhang J. Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo. Int J Clin Exp Pathol. 2014;7(11):8279–8289. [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES